Pharmaco-toxicological and clinical studies with colocynth pulp extracts (extr. colocynthidis fructus);pharmakologisch-toxikologische und klinische untersuchungen mit koloquinthenfruchtextrakten (extr. colocynthidis fructus)

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 11, 2005, Pages 621-663

  Lorenz, Peter Rolf ^a   Lippmann, Frank ^b   Dürrling, Katrin ^b   Solf, Mathias ^b   Geißler, Jürgen ^b  

^a MediFo GmbH Medizinische Forschung   (Germany)

^b Buchloe und Bombastus Werke AG   (Germany)

Author keywords

Colocynth pulp, preclinical and clinical studies; Colocynthidis fructus; Laxatives

Indexed keywords

ALCOHOL; BISACODYL; CHELIDONIUM EXTRACT; COLOCYNTH; CUCURBITACIN GLYCOSIDE; DOXORUBICIN; ELECTROLYTE; ISPAGULA; LACTULOSE; LAXATIVE; MUTAGENIC AGENT; PICOSULFATE SODIUM; PLACEBO;

ACUTE TOXICITY; AMES TEST; ANIMAL CELL; BREATHING; CANCER INHIBITION; CELL STRAIN L 929; CIRCULATION; CLINICAL TRIAL; COLOCYNTHIDIS FRUCTUS; CONSTIPATION; DIURESIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EXCRETION; FEMALE; GUINEA PIG; HERB; HUMAN; IC 50; INTESTINE MOTILITY; INTOXICATION; LD 50; LETHALITY; LEUKEMIA P 388; LIVER SLICE; MALE; MAXIMUM TOLERATED DOSE; MELANOMA B16; MOUSE; NONHUMAN; RAT; REVIEW; RISK ASSESSMENT; SALVIA; SUPERNATANT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 28744445199     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296914     Document Type: Review

References (41)

1. Kasper, H., Innere Medizin, Krankheiten des Dickdarms, 4. Aufl., S. 795, Springer-Verlag, Berlin (1982)
2. Beers, M. H., Berkow, R., Bogin, R. M. et al. (Hrsg.), Das MSD Manual, Verstopfung, 6. Aufl., S. 332, Urban & Fischer, München (2000)
3. Kuntz, E., Obstipation und Obstipationsbehandlung, Folge 2: Laxantien - Wirkungsweise, Indikationen und Nebenwirkungen, Fortschr. Med. 100, 1235 (1982)
4. Abdel-Hassan, I. A., Abdel-Barry, J. A., Mohammeda, S. T., The hypoglycmic and antihyperglycemic effect of Citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits, J. Ethnopharmacol. (Ireland) 71, 325 (2000)
5. De Smet, P. A. G. M., Keller, K., Hänsel R. et al. (Hrsg.), Adverse Effects of Herbal Drugs, Citrullus Colocynthis, S. 29-36, Springer-Verlag, Berlin (1997)
6. Shah, A, H., Qureshi, S., Tariq, M. et al., Toxicity studies on six plants used in the traditional Arab system of medicine, Phytother. Res. 3, 25 (1989)
7. Barri, M. E. S., Onsa, T. O., Elawad, A. A. et al., Toxicity of five Sudanese plants to young ruminants, J. Comp. Pathol. 93, 559 (1983)
8. Elawad, A. A., Bari, E. M. A., Mahmoud, O. M. et al., The effect of citrullus colocynthis on sheep, Vet. Hum. Toxicol. 26, 481 (1984)
9. Brendler, T., Grünewald, J., Jänicke, C., Citrullus colocynthis (L.) Schrad., Heilpflanzen - herbal remedies medpharm scientific publishers, Stuttgart (1996-1999)
10. Roth, L., Dauderer, M., Kormann, K. (Hrsg.), Giftpflanzen - Pflanzengifte, Citrullus colocynthis, 4. Aufl., S. 235-237. Ecomed, München (1994)
11. Pfab, R., Vergiftungen mit der Koloquinthe (Sodomsapfel), MMW Fortschr. Med. 141, 41 (1999)
12. Adam, S. E. I., Al-Yahya, M. A., Al-Farhan, A. H., Combined toxicity of Cassia senna and Citrullus colocynthis in rats, Vet. Hum. Toxicol. 43, 70 (2001)
13. Adam, S. E. I., Al-Farhan, A. H., Al-Yahya, M. A., Effect of combined Citrullus colocynthis and Rhazya stricta use in Najdi sheep, Am. J. Chinese Med. 28, 385 (2000)
14. Gross, R., Nmila, R., Rchid, H. et al., Insulin releasing effects of citrullus colocynthis fruit extracts in isolated rat pancreas (Abstract), Diabetologia 40 (Suppl. 1), A134 (1997)
15. Wasfi, I. A., Bashir, A. K., Abdalla, A. A. et al., Antiinflammatory activity of some medicinal plants of the United Arab Emirates, Int. J. Pharmacognosy 33, 124 (1995)
16. Alkofahi, A., Batshoun, R., Qwais, W. et al., Biological activity of some Jordanian medicinal plant extracts, Fitoterapia 67, 435 (1996)
17. Al Faraj, S., Haemorrhagic colitis induced by Citrullus colocynthis, Ann. Trop. Med. Parasitol. 89, 695 (1995)
18. Lavie, D., Willner, D., Merenlender, Z., Constituents of Citrullus colocynthis, Phytochem. 3, 51 (1964)
19. Auterhoff, H., Müller, R., Über Inhaltsstoffe der pharmazeutisch verwendeten Koloquinthen, Dtsch. Apoth. Ztg. 107, 1353 (1967)
20. Cassady, J. M., Suffness, M., Anticancer agents based on natural product models, Chap. 7, Terpenoid antitumor agents, Cucurbitacins, pp. 247-257, Academic Press, New York (1980)
21. Frohne, D., Jensen (Hrsg.), Systematik des Pflanzenreiches, Cucurbitale (Koloquinthe, Cucurbitacin), 4. Aufl., S. 204-205 (1992)
22. Shohat, B., Gitter, S., Levie, B. et al., The combined effect of cucurbitacins and X-ray treatment on transplanted tumors in mice, Cancer Res. 25, 1828 (1965)
23. DAB 6 Arzneibuch, Extractum Colocynthidis - Koloquinthenextrakt, S. 118-119, R. von Deckers Verlag, Berlin (1926)
24. Martindale, The Extra Pharmacopoeia, 29th edition, Colocynth, S. 1086, The Pharmaceutical Press, London (1989)
25. BfArM, Kommission E (Hrsg.), Stoffcharakteristik: Colocynthidis fructus (Koloquinthen), Bundesanz. Nr. 164 VI a, 265 (1. 9. 1990)
26. Wolf, H. U., Achatz-Carmesin, U., Cucurbitacine, in: Hagers Handbuch der Pharmazeutischen Praxis, F. v. Bruchhausen (Hrsg), 5. Aufl., Bd. 3, Gifte, S. 357-360, Springer-Verlag, Berlin (1992)
27. Barth, A, Müller, D., Dürrling, K., In vitro investigation of a standardized dried extract of Citrullus colocynthis on liver toxicity in adult rats, Exp. Toxicol. Pathol. 54, 223 (2002)
28. Ickert, G., Zur Toxikologie der Koloquinthe, Zbl. Pharm. 118, 1159 (1979)
29. Campbell, D. E. S., Richter, W., An observational method estimating toxicity and drug actions in mice applied to 68 reference drugs, Acta Pharmacol. Toxicol. 25, 345 (1967)
30. Ames, B. N., McCann, J., Yamasaki, E., Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutation Res. 31, 347 (1975)
31. Kier, L. E., Brusick, D. J., Auletta, A. E. et al., The Salmonella typhimurium / mammalian microsomal assay. A report of the U.S. environmental Protection Agency gene-tox program. Mutation Res. 168, 69 (1986)
32. Karch, F. E., Lasagna, L. Adverse Drug Reactions. A Critical Review, J. Am. Med. Assoc. 234, 1236 (1975)
33. CPMP Working Party on Efficacy of Medicinal Products; Note for Guidance: Good Clinical Practice for Trials on Medicinal Products in the European Community (III/3976/88-EN), May 4, 1990
34. De Serres, F. J., Shelby, M. D., Recommendations on data production and analysis using the Salmonella/microsome mutagenicity assay, Mutation Res. 64, 159 (1979)
35. Claxton, L. D., Toney, S., Perry, E. et al., Assessing the effect of colony counting methods and genetic drift on Ames bioassay results, Environmental Mutagenesis 6, 331 (1984)
36. Gatehouse, D., Haworth, S., Cebula, T. et al., Recommendations for the performance of bacterial mutation assays, Mutation Res. 312, 217 (1994)
37. Madaus, G. (Hrsg.), Lehrbuch der biologischen Heilmittel, Bd. II, Georg Thieme Verlag, Leipzig (1938)
38. Roth, L., Daunderer, M., Kormann, K. (Hrsg.), Pflanzen - Pflanzengifte, Vorkommen, Wirkung, Therapie, Allergische Reaktionen, 3. Aufl., Ecomed Verlagsgesellschaft, München (1988)
39. Güttner, J. (Hrsg.), Einführung in die Versuchstierkunde, Bd. III, Versuchstierkrankheiten, Fischer Verlag, Jena (1979)
40. Turusov, V. S. (Hrsg.), Pathology of Tumors in Laboratory Animals, Bd. I, Tumors of the Rat, Internat Agency for Research on Cancer, Lyon (1976)
41. Graeves, P., Faccini, J. M., Rat Histopathology, A Glossary for the Use in Toxicity and Carcinogenicity Studies, Elsevier, Amsterdam (1984)